Bank of New York Mellon’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.7M Buy
548,207
+64,532
+13% +$2.79M ﹤0.01% 1425
2025
Q1
$16.7M Sell
483,675
-17,456
-3% -$603K ﹤0.01% 1588
2024
Q4
$13.8M Sell
501,131
-6,939
-1% -$190K ﹤0.01% 1763
2024
Q3
$12.9M Sell
508,070
-116,699
-19% -$2.97M ﹤0.01% 1805
2024
Q2
$15.8M Buy
624,769
+112,678
+22% +$2.85M ﹤0.01% 1719
2024
Q1
$15.8M Sell
512,091
-31,928
-6% -$987K ﹤0.01% 1709
2023
Q4
$22M Buy
544,019
+80,242
+17% +$3.24M ﹤0.01% 1541
2023
Q3
$12.2M Sell
463,777
-5,493
-1% -$145K ﹤0.01% 1824
2023
Q2
$8.07M Buy
469,270
+474
+0.1% +$8.15K ﹤0.01% 2056
2023
Q1
$7.77M Buy
468,796
+33,634
+8% +$558K ﹤0.01% 2059
2022
Q4
$3.32M Buy
435,162
+5,252
+1% +$40K ﹤0.01% 2568
2022
Q3
$4.27M Buy
429,910
+53,477
+14% +$532K ﹤0.01% 2370
2022
Q2
$3.42M Sell
376,433
-126,280
-25% -$1.15M ﹤0.01% 2526
2022
Q1
$5.1M Buy
502,713
+15,368
+3% +$156K ﹤0.01% 2409
2021
Q4
$8.13M Buy
487,345
+12,641
+3% +$211K ﹤0.01% 2212
2021
Q3
$22.2M Buy
474,704
+21,608
+5% +$1.01M ﹤0.01% 1666
2021
Q2
$27.6M Buy
453,096
+84,707
+23% +$5.16M 0.01% 1548
2021
Q1
$22.7M Buy
368,389
+96,607
+36% +$5.95M ﹤0.01% 1637
2020
Q4
$19.3M Buy
271,782
+23,846
+10% +$1.7M ﹤0.01% 1657
2020
Q3
$9.3M Buy
247,936
+16,534
+7% +$620K ﹤0.01% 1891
2020
Q2
$7.55M Buy
231,402
+6,952
+3% +$227K ﹤0.01% 1988
2020
Q1
$6.51M Buy
224,450
+144,812
+182% +$4.2M ﹤0.01% 1934
2019
Q4
$2.79M Buy
79,638
+19,265
+32% +$675K ﹤0.01% 2624
2019
Q3
$1.3M Buy
+60,373
New +$1.3M ﹤0.01% 3008